Characterization of an inhibitory effect of pioglitazone on balloon-injured vascular smooth muscle cell growth

Metabolism: Clinical and Experimental

Volumn 50, Issue 8, 2001, Pages 955-962

  Igarashi, M ^a   Hirata, A ^a   Yamaguchi, H ^a   Tsuchiya, H ^a   Ohnuma, H ^a   Tominaga, M ^a   Daimon, M ^a   Kato, T ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; CELL PROTEIN; DNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PIOGLITAZONE; PROTEIN KINASE; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BALLOON CATHETER; BLOOD VESSEL INJURY; CAROTID ARTERY; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG INHIBITION; GROWTH INHIBITION; INTIMA; MALE; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0034864919     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2001.24869     Document Type: Article

References (45)

1. The pathogenesis of atherosclerosis - An update
2. Update on the pathogenesis of atherosclerosis
3. The pathogenesis of coronary artery disease and acute coronary syndrome (1)
4. Migration of smooth muscle and endothelial cells
5. The pathogenesis of atherosclerosis - A perspective for the 1990s
6. ACE-inhibition promotes apoptosis after balloon injury of rat carotid arteries
7. Antiatherosclerotic effects of the angiotensin-converting enzyme inhibitors captopril and fosinopril in hypercholesterolemic minipigs
8. Carvedilol, a cardiovascular drug prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury
9. Effects of a new calcium antagonist, CD-832, on coronary and systemic hemodynamics in conscious dogs
10. Anti-atherosclerotic activity of inhibitors of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase in cholesterol-fed rabbits: A biochemical and morphological evaluation
11. Effect of cerivastatin sodium, a new inhibitor of HMG-CoA reductase, on plasma lipid levels, progression of atherosclerosis, and the lesional composition in the plaques of WHHL rabbits
12. Repeated balloon injury of rat aorta. A model of neointima with attenuated inhibition by heparin
13. New oral thiazolidinedione antidiabetic agents act as insulin sensitizers
14. Glucose transport deficiency in diabetic animals is corrected by treatment with the oral antihyperglycemic agent pioglitazone
15. Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure in obese, insulin-resistant rhesus monkeys
16. Effect of pioglitazone on glucose and lipid metabolism in Wistar fatty rats
17. Metabolic effects of new oral hypogly cemic agent CS-045 in NIDDM subjects
18. An antidiabetic thiazolinedione is a high-affinity ligand for peroxisome proliferator-activated receptor γ (PPAR γ)
19. Pioglitazone attenuates hypertension and inhibits growth of renal arteriolar smooth muscle in rats
20. Pioglitazone reduces smooth muscle cell density of rat carotid arterial intima induced by balloon catheterization
21. Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia
22. Effect of troglitazone and pioglitazone on cytokine-mediated endothelial cell proliferation in vitro
23. Effect of troglitazone and pioglitazone on the action potentials and membrane currents of rabbit ventricular myocytes
24. Inhibitory action of insulin-sensitizing agents on calcium channels in smooth muscle cells from resistance arteries of guinea pig
25. Effects of pioglitazone on calcium channels in vascular smooth muscle
26. Use of avidin-biotin-peroxidase complex (ABC) in immuno-peroxidase technique: A comparison between ABC and unlabeled antibody (PAP) procedures
27. Enhanced arterial intimal thickening after balloon catheter injury in diabetic animals accompanied by PDGF β-receptor overexpression of aortic media
28. Protein measurement with the folin phenol reagent
29. Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways
30. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
31. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells
32. The MAPK signaling cascade
33. β-Chemokine receptor CCR5 signals via the novel tyrosine kinase RAFTK
34. Activation of Pyk2 by stress signals and coupling with JNK signaling pathway
35. Role of transactivation of EGF receptor in signaling by G-protein-coupled receptors
36. Signaling from G-protein-coupled receptors to mitogen-activated protein (MAP) kinase cascades
37. 411 in vascular smooth muscle cells: Possible requirement of epidermal growth factor receptor, Ras, extracellular signal-regulated kinase, and Akt
38. ++-induced regulation of ion channel and MAP kinase functions
39. 2+-dependent mitogen-activated protein kinase activation in spontaneously hypertensive rat vascular smooth muscle defines a hypertensive signal transduction phenotype
40. 2+ and PKC in activation of mitogen-activated protein (MAP) kinase in human polymorphonuclear neutrophils
41. 1 receptor gene expression by posttranscriptional mechanisms
42. Involvement of PYK2 in angiotensin II signaling of vascular smooth muscle cells
43. Peroxisome proliferator-activated receptor g activators downregulate angiotensin II type 1 receptor in vascular smooth muscle cells
44. Suppression of mesangial proliferative glomerulonephritis development in rats by inhibitors of cAMP phosphodiesterase isozymes types III and IV
45. PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL